DADLE suppresses the proliferation of human liver cancer HepG2 cells by activation of PKC pathway and elevates the sensitivity to cis-diammine dichloridoplatium

Chinese Journal of Oncology

Volumn 34, Issue 6, 2012, Pages 425-429

  Tang, Bo ^a   Du, Jian ^a   Gao, Zhen Ming ^a   Liang, Rui ^a   Sun, De Guang ^a   Jin, Xue Li ^a   Wang, Li Ming ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Hepatocellular carcinoma; HepG2 cell line; Protein kinase C; Receptor, opioid

Indexed keywords

CISPLATIN; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; PROTEIN KINASE C;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL PROLIFERATION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ENKEPHALIN, LEUCINE-2-ALANINE; HEP G2 CELLS; HUMANS; NALTREXONE; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, OPIOID, DELTA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 84864190010     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.06.006     Document Type: Article

References (19)

1. Wörns MA, Galle PR. Future perspectives in hepatocellular carcinoma. Dig Liver Dis, 2010, 3:S302-309.
2. Rampone B, Schiavone B, Martino A, et al. Current management strategy of hepatocellular carcinoma. World J Gastroenterol, 2009, 15:3210-3216.
3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 132:2557-2576. (Pubitemid 46890874)
4. Heiss A, Ammer H, Eisinger DA. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation. Exp Cell Res, 2009, 315:2115-2125.
5. Madar I, Bencherif B, Lever J, et al. Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med, 2007, 48:207-213. (Pubitemid 47555345)
6. Debruyne D, Leroy A, DE Wever O, et al. Direct effects of delta opioid receptor agonists on invasion-associated activities of HCT-8/E11 colon cancer cells. Anticancer Res, 2010, 30:9-17.
7. Nicoll J, Axiotis CA, Bergasa NV. The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses, 2005, 65:1099-1105. (Pubitemid 41425896)
8. Bergasa NV, Boyella VD. Liver derived endogenous opioids may interfere with the therapeutic effect of interferon in chronic hepatitis C. Med Hypotheses, 2008, 70:556-559.
9. De Minicis S, Candelaresi C, Marzioni M, et al. Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. Gut, 2008, 57:352-364. (Pubitemid 351288102)
10. Zhuge J, Cederbaum AI. Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1. Free Radic Biol Med, 2006, 40:63-74. (Pubitemid 41759404)
11. Yang L, Parkin DM, Li L, et al. A comparison of the sources of cancer mortality in China. Cancer Causes Control, 2004, 15:681-687. (Pubitemid 39060930)
12. Zagon IS, Verderame MF, Zimmer WE, et al. Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse. Brain Res Mol Brain Res, 2000, 84:106-114.
13. Hatzoglou A, Kampa M, Castanas E. Opioid-somatostatin interactions in regulating cancer cell growth. Front Biosci, 2005, 10:244-256. (Pubitemid 40552762)
14. Avella DM, Kimchi ET, Donahue RN, et al. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer. Am J Physiol Regul Integr Comp Physiol, 2010, 298:R459-466.
15. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol, 1997, 29:2187-2195. (Pubitemid 27348529)
16. Pateliya BB, Singh N, Jaggi AS. Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull, 2008, 31:1755-1760.
17. Zhao M, Wang HX, Yang J, et al. delta-Opioid receptor stimulation enhances the growth of neonatal rat ventricular myocytes via the extracellular signal-regulated kinase pathway. Clin Exp Pharmacol Physiol, 2008, 35:97-102. (Pubitemid 350197692)
18. Capiati DA, Vazquez G, Tellez Iñón MT, et al. Antisense oligonucleotides targeted against protein kinase c alpha inhibit proliferation of cultured avian myoblasts. Cell Prolif, 2000, 33:307-315.
19. Basu A, Akkaraju GR. Regulation of caspase activation and cis-diamminedichloroplatinum (II)-induced cell death by protein kinase C. Biochemistry, 1999, 38:4245-4251. (Pubitemid 29172183)